Administration of (3S)-N-hydroxy-4-(sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide or (S)-N_hydroxy-4-[4_(but-2-ynyloxy)phenylsulfonyl]-2,2-dimethyl thimomorpholine-3-carboxamide for preventing and/or treating inflammatory skin pathologies/afflictions
Inflammatory skin pathologies/afflictions, e.g., eczema or psoriasis, are prevented and/or treated by administering to a subject in need of such treatment, a thus effective amount of at least one compound of following formula (I): in which R is a -CH3 radical or a CH2OH radical, or of a pharmaceutic...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
28.05.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Inflammatory skin pathologies/afflictions, e.g., eczema or psoriasis, are prevented and/or treated by administering to a subject in need of such treatment, a thus effective amount of at least one compound of following formula (I): in which R is a -CH3 radical or a CH2OH radical, or of a pharmaceutically acceptable salt, solvate or hydrate thereof. |
---|---|
Bibliography: | Application Number: US20080232456 |